FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306319664> ?p ?o ?g. }

• W4306319664 abstract "Abstract Background Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a clinical entity with a plethora of causes and pathophysiologic mechanisms. Traditional secondary prevention medications may not offer benefit for patients with MINOCA, calling into question the routine use of such therapies in this population. Material and methods Literature search was conducted in MEDLINE (PubMed), Scopus by ELSEVIER and Cochrane Central Register of Controlled Trials (CENTRAL) databases until 08 March 2022. Random-effects frequentist and hierarchical Bayesian meta-analyses were performed to assess the prognostic impact of secondary prevention medications (β-blockers, RAAS inhibitors, statins, DAPT, ASA and P2Y12 inhibitors) on the occurrence of major adverse cardiovascular events (MACE) and all-cause mortality in MINOCA patients. Sensitivity analyses accounted for the effect of: i. small sample size, ii. limited study follow-up period, and iii. different ethnicity. Results Of 2,569 articles initially retrieved, 9 observational studies were deemed eligible for this analysis, encompassing a total of 14,003 patients suffering from MINOCA (mean follow-up range from 6 to 90 months, mean age = 64.9±10.4 years).Administration of ASA, DAPT and P2Y12 inhibitors was not significantly linked with MACE [pooled adjusted hazard ratios (aHRs) = 0.94, 0.88, and 0.97, with 95% confidence intervals (CIs): 0.56–1.59, 0.47–1.65, and 0.562–1.53, respectively]. RAAS inhibitors and statins were independently associated with lower risk of MACE (pooled aHRs = 0.61 and 0.55 with 95% Cis: 0.46–0.82, and 0.34–0.90, respectively) and all-cause mortality (pooled aHRs = 0.58 and 0.55 with 95% Cis: 0.37–0.91, and 0.43–0.72, respectively). B-blockers were associated with significantly lower risk of all-cause death according to the frequentist analysis (pooled aHR = 0.80, 95% CI: 0.67–0.96) and with non-significantly lower risk of MACE (pooled aHR = 0.81, 95% CI: 0.65–1.01) [Figure 1]. The results deriving from the Bayesian analyses were generally consistent with the frequentist analyses, with the exceptions of the Bayesian analyses on statin and β-blocker effects, which were affected by the pre-test probabilities set herein [Figure 2]. The overall heterogeneity observed in our analyses was relatively small, and there was not substantial publication bias. Furthermore, the performed sensitivity analyses supported the robustness of the observed outcomes. Conclusion In this meta-analysis, it appeared that predominantly RAAS inhibitors and statins across secondary prevention medications were consistently associated with lower risk of MACE or all-cause death during the follow-up period of patients that experienced MINOCA. Funding Acknowledgement Type of funding sources: None." @default.
• W4306319664 created "2022-10-16" @default.
• W4306319664 creator A5003352897 @default.
• W4306319664 creator A5045803379 @default.
• W4306319664 creator A5053464595 @default.
• W4306319664 creator A5059491860 @default.
• W4306319664 creator A5065787663 @default.
• W4306319664 creator A5074737994 @default.
• W4306319664 creator A5088290603 @default.
• W4306319664 date "2022-10-01" @default.
• W4306319664 modified "2023-09-26" @default.
• W4306319664 title "Prognostic impact of secondary prevention treatment following myocardial infarction with non-obstructive coronary arteries: Bayesian versus frequentist meta-analysis" @default.
• W4306319664 doi "https://doi.org/10.1093/eurheartj/ehac544.1457" @default.
• W4306319664 hasPublicationYear "2022" @default.
• W4306319664 type Work @default.
• W4306319664 citedByCount "0" @default.
• W4306319664 crossrefType "journal-article" @default.
• W4306319664 hasAuthorship W4306319664A5003352897 @default.
• W4306319664 hasAuthorship W4306319664A5045803379 @default.
• W4306319664 hasAuthorship W4306319664A5053464595 @default.
• W4306319664 hasAuthorship W4306319664A5059491860 @default.
• W4306319664 hasAuthorship W4306319664A5065787663 @default.
• W4306319664 hasAuthorship W4306319664A5074737994 @default.
• W4306319664 hasAuthorship W4306319664A5088290603 @default.
• W4306319664 hasBestOaLocation W43063196641 @default.
• W4306319664 hasConcept C126322002 @default.
• W4306319664 hasConcept C164705383 @default.
• W4306319664 hasConcept C207103383 @default.
• W4306319664 hasConcept C2780400711 @default.
• W4306319664 hasConcept C2780739214 @default.
• W4306319664 hasConcept C44249647 @default.
• W4306319664 hasConcept C500558357 @default.
• W4306319664 hasConcept C71924100 @default.
• W4306319664 hasConcept C95190672 @default.
• W4306319664 hasConceptScore W4306319664C126322002 @default.
• W4306319664 hasConceptScore W4306319664C164705383 @default.
• W4306319664 hasConceptScore W4306319664C207103383 @default.
• W4306319664 hasConceptScore W4306319664C2780400711 @default.
• W4306319664 hasConceptScore W4306319664C2780739214 @default.
• W4306319664 hasConceptScore W4306319664C44249647 @default.
• W4306319664 hasConceptScore W4306319664C500558357 @default.
• W4306319664 hasConceptScore W4306319664C71924100 @default.
• W4306319664 hasConceptScore W4306319664C95190672 @default.
• W4306319664 hasIssue "Supplement_2" @default.
• W4306319664 hasLocation W43063196641 @default.
• W4306319664 hasOpenAccess W4306319664 @default.
• W4306319664 hasPrimaryLocation W43063196641 @default.
• W4306319664 hasRelatedWork W1505721632 @default.
• W4306319664 hasRelatedWork W2020050573 @default.
• W4306319664 hasRelatedWork W2089715561 @default.
• W4306319664 hasRelatedWork W2100465349 @default.
• W4306319664 hasRelatedWork W2249318501 @default.
• W4306319664 hasRelatedWork W2399063111 @default.
• W4306319664 hasRelatedWork W2885951725 @default.
• W4306319664 hasRelatedWork W2902149400 @default.
• W4306319664 hasRelatedWork W416619884 @default.
• W4306319664 hasRelatedWork W4315783144 @default.
• W4306319664 hasVolume "43" @default.
• W4306319664 isParatext "false" @default.
• W4306319664 isRetracted "false" @default.
• W4306319664 workType "article" @default.